
Inbios International Inc
Innovative Diagnostics for Infectious Diseases
Seattle, United States · Founded 2015 · $20.8M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- inbios.com
- Total Funding
- $20.8M
- Last Round
- $12.7M GrantNov 2022
About
InBios International specializes in the design, development, and manufacture of diagnostic assays for emerging infectious diseases and biothreats. Based in Seattle, Washington, the company offers immunodiagnostic products for diseases including dengue, chikungunya, West Nile virus, and Chagas disease. InBios is GMP compliant, FDA registered, USDA licensed, and ISO 13485:2016 certified.
Summary
Inbios International Inc is a Biotech company based in Seattle, United States, founded in 2015. It has raised $20.8M in total, most recently a $12.7M Grant round in Nov 2022.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...